Rezolute Inc [RZLT] stock is trading at $1.85, down -7.96%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RZLT shares have gain 32.14% over the last week, with a monthly amount drifted -81.79%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Rezolute Inc [NASDAQ: RZLT] stock has seen the most recent analyst activity on December 11, 2025, when Wedbush downgraded its rating to a Neutral but kept the price target unchanged to $1 for it. Previously, Craig Hallum downgraded its rating to Hold on December 11, 2025, and kept the price target unchanged to $2. On December 11, 2025, downgrade downgraded it’s rating to Neutral. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $12 on November 05, 2024. Guggenheim initiated its recommendation with a Buy and recommended $11 as its price target on August 27, 2024. BTIG Research started tracking with a Buy rating for this stock on July 17, 2024, and assigned it a price target of $13. In a note dated June 04, 2024, Craig Hallum initiated an Buy rating and provided a target price of $14 on this stock.
Rezolute Inc [RZLT] stock has fluctuated between $1.07 and $11.46 over the past year. Currently, Wall Street analysts expect the stock to reach $7.71 within the next 12 months. Rezolute Inc [NASDAQ: RZLT] shares were valued at $1.85 at the most recent close of the market. An investor can expect a potential return of 316.76% based on the average RZLT price forecast.
Analyzing the RZLT fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -0.63 and Total Capital is -0.56. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.72 points at the first support level, and at 1.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.09, and for the 2nd resistance point, it is at 2.34.
Ratios To Look Out For
For context, Rezolute Inc’s Current Ratio is 15.15. In addition, the Quick Ratio stands at 15.15 and the Cash Ratio stands at 0.89.
Transactions by insiders
Recent insider trading involved Hogenhuis Wladimir, Director, that happened on Dec 16 ’25 when 5650.0 shares were purchased. Chief Medical Officer, ROBERTS BRIAN KENNETH completed a deal on Dec 16 ’25 to buy 28000.0 shares. Meanwhile, CFO Evans Daron bought 40000.0 shares on Dec 15 ’25.
